510(k) Report

FDA applicant

Accelerate Diagnostics, Inc.

Tucson, AZ2 decisions2020–20242 recalls

FDA records 2 decisions for Accelerate Diagnostics, Inc. (Tucson, AZ) from 2020 to 2024: 2 510(k) clearances. Most are in product codes PRH (Positive Blood Culture Identification And Ast…) and QNJ (Mass Spectrometry, Microorganism…). Its devices cite 2 predicates, 0 of them its own earlier devices. 2 recalls are linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, microbiology panel, where it files most

How often FDA has decided Accelerate Diagnostics, Inc.’s devices, and how often a recall has named them.

FDA decisions per year

1in 2024

2020: 12024: 1
2020high 1 (2020) · low 0 (2021)2026

2026 so far, outlined.

Recalls per year

2in 2022

2022: 2
2020high 2 (2022) · low 0 (2020)2026

Class I Class II/III not classified

FIG. 1 — Accelerate Diagnostics, Inc. by year, 2020–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Accelerate Diagnostics, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Other applicant names beginning “Accelerate”

FDA records each applicant name separately; these may or may not be the same firm.